TY - JOUR
T1 - Waist circumference as a vital sign in clinical practice
T2 - a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
AU - Ross, Robert
AU - Neeland, Ian J.
AU - Yamashita, Shizuya
AU - Shai, Iris
AU - Seidell, Jaap
AU - Magni, Paolo
AU - Santos, Raul D.
AU - Arsenault, Benoit
AU - Cuevas, Ada
AU - Hu, Frank B.
AU - Griffin, Bruce A.
AU - Zambon, Alberto
AU - Barter, Philip
AU - Fruchart, Jean Charles
AU - Eckel, Robert H.
AU - Matsuzawa, Yuji
AU - Després, Jean Pierre
N1 - Funding Information:
The authors acknowledge the financial support of the IAS and the ICCR, an independent academic organization based at Université Laval, Québec, Canada, who were responsible for coordinating the production of our report. No funding or honorarium was provided by either the IAS or the ICCR to the members of the writing group for the production of this article. The scientific director of the ICCR (J.-P.D.) is funded by a Foundation Grant (Funding Reference Number FDN-167278) from the Canadian Institutes of Health Research.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Despite decades of unequivocal evidence that waist circumference provides both independent and additive information to BMI for predicting morbidity and risk of death, this measurement is not routinely obtained in clinical practice. This Consensus Statement proposes that measurements of waist circumference afford practitioners with an important opportunity to improve the management and health of patients. We argue that BMI alone is not sufficient to properly assess or manage the cardiometabolic risk associated with increased adiposity in adults and provide a thorough review of the evidence that will empower health practitioners and professional societies to routinely include waist circumference in the evaluation and management of patients with overweight or obesity. We recommend that decreases in waist circumference are a critically important treatment target for reducing adverse health risks for both men and women. Moreover, we describe evidence that clinically relevant reductions in waist circumference can be achieved by routine, moderate-intensity exercise and/or dietary interventions. We identify gaps in the knowledge, including the refinement of waist circumference threshold values for a given BMI category, to optimize obesity risk stratification across age, sex and ethnicity. We recommend that health professionals are trained to properly perform this simple measurement and consider it as an important ‘vital sign’ in clinical practice.
AB - Despite decades of unequivocal evidence that waist circumference provides both independent and additive information to BMI for predicting morbidity and risk of death, this measurement is not routinely obtained in clinical practice. This Consensus Statement proposes that measurements of waist circumference afford practitioners with an important opportunity to improve the management and health of patients. We argue that BMI alone is not sufficient to properly assess or manage the cardiometabolic risk associated with increased adiposity in adults and provide a thorough review of the evidence that will empower health practitioners and professional societies to routinely include waist circumference in the evaluation and management of patients with overweight or obesity. We recommend that decreases in waist circumference are a critically important treatment target for reducing adverse health risks for both men and women. Moreover, we describe evidence that clinically relevant reductions in waist circumference can be achieved by routine, moderate-intensity exercise and/or dietary interventions. We identify gaps in the knowledge, including the refinement of waist circumference threshold values for a given BMI category, to optimize obesity risk stratification across age, sex and ethnicity. We recommend that health professionals are trained to properly perform this simple measurement and consider it as an important ‘vital sign’ in clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=85079117317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079117317&partnerID=8YFLogxK
U2 - 10.1038/s41574-019-0310-7
DO - 10.1038/s41574-019-0310-7
M3 - Article
C2 - 32020062
AN - SCOPUS:85079117317
SN - 1759-5029
VL - 16
SP - 177
EP - 189
JO - Nature Clinical Practice Endocrinology and Metabolism
JF - Nature Clinical Practice Endocrinology and Metabolism
IS - 3
ER -